These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3947106)

  • 1. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
    Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H; Iguchi H; Tone H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A; Yamashita K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
    Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
    Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4'-O-tetrahydropyranyladriamycin has greater antineoplastic activity than adriamycin in various human tumours in vitro.
    Maehara Y; Sakaguchi Y; Kusumoto T; Kusumoto H; Sugimachi K
    Anticancer Res; 1989; 9(2):387-9. PubMed ID: 2751263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and disposition of (2''R)-4'-O-tetrahydropyranyladriamycin in dogs.
    Iguchi H; Tone H; Kiyosaki T; Ishikura T; Takeuchi T; Umezawa H
    Jpn J Antibiot; 1986 Feb; 39(2):638-52. PubMed ID: 3712763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tissue concentration of 4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor].
    Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Shomura T; Kawamura K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1975-9. PubMed ID: 4051513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].
    Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T
    Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THP-adriamycin in head and neck tumor].
    Honda T; Ohyama W; Sonoda T; Uchida K; Hirokawa T; Takada K; Takeda C
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2538-44. PubMed ID: 6651307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H; Munck JN; Fourcade A
    Drugs Exp Clin Res; 1986; 12(1-3):257-64. PubMed ID: 3460752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of doxorubicin and epirubicin in patients with gastrointestinal cancer.
    Peterson C; Gunvén P; Theve NO
    Cancer Treat Rep; 1986 Aug; 70(8):947-52. PubMed ID: 3460699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies of (2''R)-4'-O-tetrahydropyranyl adriamycin (THP).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):237-43. PubMed ID: 3311190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1893-900. PubMed ID: 3164181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
    Preiss R; Sohr R; Kittelmann B; Müller E; Haase D
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):156-64. PubMed ID: 2714916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.